Nicolas André
High-level Meeting on Non-communicable Diseases
High-level Meeting on Non-communicable Diseases
Background
The General Assembly in its resolution A/RES/65/238 decided that the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases shall be held on 19 and 20 September 2011 in New York and that the high-level meeting shall address the prevention and[...]
Cancer joins AIDS, malaria as global health issue
Cancer joins AIDS, malaria as global health issue
The fight against diseases like AIDS, malaria and tuberculosis has made Seattle a center for global health.
Now, increasingly, the battle is including cancer — which might seem ridiculously impossible. Isn’t it hard enough to fight infectious diseases in poor countries? Can we afford to start[...]
Global move needed to battle cancer in poor countries
Global move needed to battle cancer in poor countries
(AFP) – Jun 6, 2011
CHICAGO — A broad international effort is needed to halt the rapid spread of cancer in poor and middle-income countries, leaders from world cancer organizations said at a meeting in Chicago. The call for action came at the 47th annual conference of the American Society of[...]
Metro-Mali02
After completing Metro-Mali 01 we aimed at developing a protocol that would be more efficient without increasing cost nor toxicity.
We designed Metro-Mali 02 as a combination of metromomic chemotherapy and drug repositioning. Thus we added valproic acid as an HDAC inhibitor, an established new anticancer strategy. Valproic acid has already been[...]
Drug Repositioning
A model of sustainable drug development: recycling old drugs to turn them into long term anti-cancer targeted therapies
Drug repositioning consists in using old drugs for new indications. The theoretical and pragmatic advantages to testing already established drugs for a potential effect on cancer cells are clear. The side-effects are known and have[...]
Metronomic Chemotherapy
Metronomic chemotherapy is based on the chronic administration of chemotherapeutic agents at relatively low, minimally toxic doses, and with no prolonged drug-free breaks
■ Metronomic chemotherapy was originally developed to overcome drug resistance by shifting therapeutic target from tumor cells to tumor vasculature
■ In the past decade, several[...]
Join in !
if you share our vision, if you think you can help us to make our dream come true, if you think we can help you with your own projects.
do not hesitate.
Contact us :
Nicolas ANDRE
Service d’Hématologie et Oncologie Pédiatrique
Hôpital pour Enfants de La Timone
AP-HM, Marseille
France.
mail : nicolas.andre@ap-hm.fr
Metronomic preclinical models
Preclinical research is a crucial step toward the development of efficient anticancer treatments.
The preclinical testing of metronomic treatments for children in developing countries is an important issue. These children often present with advanced metastatic disease that our model should reproduce.
Children are also frequently suffering from[...]
A logo for the Metronomic Global Health Initiative
Here it is : The earth, the metronome, in our hands....
One planet, One People, One vision
More with less for All ?
We can do it
Together !
With the participation of: Nicolas André
Venture philanthropy
Giving can make you feel good, giving can make you a better person: you are waiting for the right cause, we can give you the oppotunity be that beter person.
If you believe in our action and want to be the one who made it happen by giving us the means to to put it into practice. You can help us by giving financial capital. Funding on a multi-year[...]
